+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Exosome Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030- Product Image
Exosome Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030- Product Image
New

Exosome Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

  • PDF Icon

    Report

  • 180 Pages
  • November 2025
  • Region: Global
  • TechSci Research
  • ID: 5768487
Free Webex Call
10% Free customization
Description Jump to:

Natural Exosomes is the fastest growing segment, North America is the largest market globally

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Global Exosome Therapeutics Market, valued at USD 32.63 Million in 2024, is projected to experience a CAGR of 41.56% to reach USD 262.58 Million by 2030. Exosome therapeutics involve the utilization of naturally occurring, cell-derived nanovesicles that facilitate intercellular communication and deliver bioactive molecules to target cells, presenting novel therapeutic avenues for various diseases. The market's expansion is fundamentally supported by an escalating understanding of exosome biology, the increasing prevalence of chronic and age-related conditions necessitating advanced treatment modalities, and substantial investment in biotechnology research and development

Key Market Drivers

The increasing incidence of chronic diseases, particularly cancer, serves as a significant driver for the global exosome therapeutics market. Exosomes offer novel therapeutic avenues through their natural ability to facilitate targeted drug delivery and enable minimally invasive diagnostics, addressing limitations of current treatments. This escalating disease burden necessitates innovative solutions that exosomes are uniquely positioned to provide, aiming for improved efficacy and reduced systemic toxicity. According to the International Agency for Research on Cancer, in 2022, there were close to 20 million new cases of cancer worldwide, highlighting the pressing need for advanced therapeutic strategies and emphasizing the expansive patient population that exosome-based therapies could potentially benefit.

Key Market Challenges

The complexity and cost associated with the large-scale manufacturing and purification of clinical-grade exosomes represent a significant impediment to the expansion of the global exosome therapeutics market. Achieving the necessary purity and quantity of exosomes for clinical applications demands sophisticated and resource-intensive processes, which drives up production expenses. This directly hampers the market by delaying the progression of promising therapies from research and development into commercialization. The intricate nature of isolating and purifying exosomes to meet stringent regulatory standards often results in lower yields and higher per-dose costs, making advanced exosome-based treatments less accessible and financially viable for wider adoption.

Key Market Trends

This involves actively modifying exosomes to enhance their intrinsic capabilities for precise drug delivery and increased therapeutic efficacy, moving beyond their natural properties. Companies are increasingly focusing on engineering exosomes to carry specific payloads directly to disease sites, thereby improving treatment outcomes and minimizing off-target effects. For example, Minovacca, a startup incorporated in January 2025, commercializes universal milk exosomes by chemically and genetically engineering them for target-specific delivery of therapeutics, highlighting this directed approach. This scientific progression is underpinned by extensive collaborative efforts; according to the International Society for Extracellular Vesicles (ISEV), its MISEV2023 guidelines, published in December 2023, incorporated feedback from over 1000 researchers worldwide to standardize and advance exosome research methods, a foundational step for effective exosome engineering.

Key Market Players Profiled:

  • Aethlon Medical, Inc.
  • AEGLE Therapeutics Corporation
  • Anjarium Biosciences AG
  • Exogenus Therapeutics SA
  • Lonza Group AG
  • Capricor Therapeutics Inc
  • Avalon GloboCare Corp.
  • Stem Cell Medicine Ltd.
  • Evox Therapeutics Limited.
  • EV Therapeutics

Report Scope:

In this report, the Global Exosome Therapeutics Market has been segmented into the following categories:

By Exosome Type:

  • Natural
  • Hybrid

By Source:

  • Mesenchymal Stem Cells
  • Blood
  • Body Fluids
  • Others

By Therapy:

  • Immunotherapy
  • Chemotherapy
  • Gene Therapy

By Application:

  • Metabolic Disorders
  • Oncology
  • Cardiac Disorders
  • Neurology
  • Others

By End User:

  • Hospitals & Clinics
  • Academic & Research Institutions
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Exosome Therapeutics Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:
  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Exosome Therapeutics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Exosome Type (Natural, Hybrid)
5.2.2. By Source (Mesenchymal Stem Cells, Blood, Body Fluids, Others)
5.2.3. By Therapy (Immunotherapy, Chemotherapy, Gene Therapy)
5.2.4. By Application (Metabolic Disorders, Oncology, Cardiac Disorders, Neurology, Others)
5.2.5. By End User (Hospitals & Clinics, Academic & Research Institutions, Others)
5.2.6. By Region
5.2.7. By Company (2024)
5.3. Market Map
6. North America Exosome Therapeutics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Exosome Type
6.2.2. By Source
6.2.3. By Therapy
6.2.4. By Application
6.2.5. By End User
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Exosome Therapeutics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Exosome Type
6.3.1.2.2. By Source
6.3.1.2.3. By Therapy
6.3.1.2.4. By Application
6.3.1.2.5. By End User
6.3.2. Canada Exosome Therapeutics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Exosome Type
6.3.2.2.2. By Source
6.3.2.2.3. By Therapy
6.3.2.2.4. By Application
6.3.2.2.5. By End User
6.3.3. Mexico Exosome Therapeutics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Exosome Type
6.3.3.2.2. By Source
6.3.3.2.3. By Therapy
6.3.3.2.4. By Application
6.3.3.2.5. By End User
7. Europe Exosome Therapeutics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Exosome Type
7.2.2. By Source
7.2.3. By Therapy
7.2.4. By Application
7.2.5. By End User
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Exosome Therapeutics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Exosome Type
7.3.1.2.2. By Source
7.3.1.2.3. By Therapy
7.3.1.2.4. By Application
7.3.1.2.5. By End User
7.3.2. France Exosome Therapeutics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Exosome Type
7.3.2.2.2. By Source
7.3.2.2.3. By Therapy
7.3.2.2.4. By Application
7.3.2.2.5. By End User
7.3.3. United Kingdom Exosome Therapeutics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Exosome Type
7.3.3.2.2. By Source
7.3.3.2.3. By Therapy
7.3.3.2.4. By Application
7.3.3.2.5. By End User
7.3.4. Italy Exosome Therapeutics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Exosome Type
7.3.4.2.2. By Source
7.3.4.2.3. By Therapy
7.3.4.2.4. By Application
7.3.4.2.5. By End User
7.3.5. Spain Exosome Therapeutics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Exosome Type
7.3.5.2.2. By Source
7.3.5.2.3. By Therapy
7.3.5.2.4. By Application
7.3.5.2.5. By End User
8. Asia Pacific Exosome Therapeutics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Exosome Type
8.2.2. By Source
8.2.3. By Therapy
8.2.4. By Application
8.2.5. By End User
8.2.6. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Exosome Therapeutics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Exosome Type
8.3.1.2.2. By Source
8.3.1.2.3. By Therapy
8.3.1.2.4. By Application
8.3.1.2.5. By End User
8.3.2. India Exosome Therapeutics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Exosome Type
8.3.2.2.2. By Source
8.3.2.2.3. By Therapy
8.3.2.2.4. By Application
8.3.2.2.5. By End User
8.3.3. Japan Exosome Therapeutics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Exosome Type
8.3.3.2.2. By Source
8.3.3.2.3. By Therapy
8.3.3.2.4. By Application
8.3.3.2.5. By End User
8.3.4. South Korea Exosome Therapeutics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Exosome Type
8.3.4.2.2. By Source
8.3.4.2.3. By Therapy
8.3.4.2.4. By Application
8.3.4.2.5. By End User
8.3.5. Australia Exosome Therapeutics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Exosome Type
8.3.5.2.2. By Source
8.3.5.2.3. By Therapy
8.3.5.2.4. By Application
8.3.5.2.5. By End User
9. Middle East & Africa Exosome Therapeutics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Exosome Type
9.2.2. By Source
9.2.3. By Therapy
9.2.4. By Application
9.2.5. By End User
9.2.6. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Exosome Therapeutics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Exosome Type
9.3.1.2.2. By Source
9.3.1.2.3. By Therapy
9.3.1.2.4. By Application
9.3.1.2.5. By End User
9.3.2. UAE Exosome Therapeutics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Exosome Type
9.3.2.2.2. By Source
9.3.2.2.3. By Therapy
9.3.2.2.4. By Application
9.3.2.2.5. By End User
9.3.3. South Africa Exosome Therapeutics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Exosome Type
9.3.3.2.2. By Source
9.3.3.2.3. By Therapy
9.3.3.2.4. By Application
9.3.3.2.5. By End User
10. South America Exosome Therapeutics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Exosome Type
10.2.2. By Source
10.2.3. By Therapy
10.2.4. By Application
10.2.5. By End User
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Exosome Therapeutics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Exosome Type
10.3.1.2.2. By Source
10.3.1.2.3. By Therapy
10.3.1.2.4. By Application
10.3.1.2.5. By End User
10.3.2. Colombia Exosome Therapeutics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Exosome Type
10.3.2.2.2. By Source
10.3.2.2.3. By Therapy
10.3.2.2.4. By Application
10.3.2.2.5. By End User
10.3.3. Argentina Exosome Therapeutics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Exosome Type
10.3.3.2.2. By Source
10.3.3.2.3. By Therapy
10.3.3.2.4. By Application
10.3.3.2.5. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Exosome Therapeutics Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Aethlon Medical, Inc.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. AEGLE Therapeutics Corporation
15.3. Anjarium Biosciences AG
15.4. Exogenus Therapeutics SA
15.5. Lonza Group AG
15.6. Capricor Therapeutics Inc
15.7. Avalon GloboCare Corp.
15.8. Stem Cell Medicine Ltd.
15.9. Evox Therapeutics Limited.
15.10. EV Therapeutics
16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

  • Aethlon Medical, Inc.
  • AEGLE Therapeutics Corporation
  • Anjarium Biosciences AG
  • Exogenus Therapeutics SA
  • Lonza Group AG
  • Capricor Therapeutics Inc
  • Avalon GloboCare Corp.
  • Stem Cell Medicine Ltd.
  • Evox Therapeutics Limited.
  • EV Therapeutics

Table Information

Report AttributeDetails
No. of Pages180
PublishedNovember 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 32.63 Million
Forecasted Market Value ( USD ) by 2030 $ 262.58 Million
Compound Annual Growth Rate41.5%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Exosome Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Exosome Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Exosome Diagnostic and Therapeutic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Exosome Diagnostic and Therapeutic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 184 Pages
  • Global
From
Exosome Diagnostic and Therapeutic Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Exosome Diagnostic and Therapeutic Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Exosome Therapeutics Market Industry Trends and Global Forecasts to 2035, by Type of Therapeutic, Target Indication, Therapeutic Area, Route of Administration and Geography - Product Image

Exosome Therapeutics Market Industry Trends and Global Forecasts to 2035, by Type of Therapeutic, Target Indication, Therapeutic Area, Route of Administration and Geography

  • Report
  • 190 Pages
  • Global
From
Exosomes - Global Strategic Business Report - Product Image

Exosomes - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.